Your browser doesn't support javascript.
loading
2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity.
Lin, Hong; Yamashita, Dennis S; Zeng, Jin; Xie, Ren; Wang, Wenyong; Nidarmarthy, Sirishkumar; Luengo, Juan I; Rhodes, Nelson; Knick, Victoria B; Choudhry, Anthony E; Lai, Zhihong; Minthorn, Elisabeth A; Strum, Susan L; Wood, Edgar R; Elkins, Patricia A; Concha, Nestor O; Heerding, Dirk A.
Afiliação
  • Lin H; Oncology Medicinal Chemistry, GlaxoSmithKline, 1250 S. Collegeville, Rd., Collegeville, PA 19426, United States. hong.2.lin@gsk.com
Bioorg Med Chem Lett ; 20(2): 673-8, 2010 Jan 15.
Article em En | MEDLINE | ID: mdl-20006497
2,3,5-Trisubstituted pyridines have been designed as potent AKT inhibitors that are selective against ROCK1 based on the comparison between AKT and ROCK1 structures. Substitution at the 2-position of the core pyridine is the key element to provide selectivity against ROCK1. An X-ray co-crystal structure of 9p in PKA supports the proposed rationale of ROCK1 selectivity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-akt / Quinases Associadas a rho Limite: Humans Idioma: En Revista: Bioorg Med Chem Lett Ano de publicação: 2010 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-akt / Quinases Associadas a rho Limite: Humans Idioma: En Revista: Bioorg Med Chem Lett Ano de publicação: 2010 Tipo de documento: Article